BMO Capital Initiates Coverage On RXO with Outperform Rating, Announces Price Target of $35
RXO, Inc. Common Stock
RXO, Inc. Common Stock RXO | 0.00 |
BMO Capital analyst Fadi Chamoun initiates coverage on RXO (NYSE:
RXO) with a Outperform rating and announces Price Target of $35.
